“After progress in a second round of tests using stem cells to regrow nerve fibres, the China Spinal Cord Injury Network (ChinaSCINet) has applied for regulatory approval in China for a third and final phase, which it hopes to start in the autumn. 15 out of 20 patients in the Chinese city of Kunming, who received umbilical cord blood cell transplants and intensive walking therapy, were on average able to walk with minimal assistance seven years after complete spinal cord injury. The treatment involves injecting umbilical cord blood mononuclear cells into patients’ damaged spines to help regenerate nerves, while lithium is used to promote the growth of the nerve fibres.”
Related posts:
Elderly patients could benefit significantly from using medical marijuana
Treasury Surpasses Debt Limit on First Day of Ceiling’s Suspension
Archaeologists use revolutionary laser technology to find lost medieval city in Cambodia
The man who wanted to split California into six states now wants to make it three
Spanish spy chief to address Parliament on spying
Swiss war game envisages invasion by bankrupt French
US police departments are increasingly militarised: report
Missouri governor vetoes bill to nullify federal gun laws
Military Plans to Maintain Power in Egypt after Coup
Scotland citizenship, passport plans outlined
Egypt approves new constitution with 32.9% voter turnout
Politics leads to cancellation of only U.S. medical marijuana study
Dying Organs Restored To Life With Mitochondria Injections
Greek Party Syriza’s Rise Fueled by Professors-Turned-Politicians
Justin Amash vs Former NSA Head General Michael Hayden 8/4/13